Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane-ephrin receptor activity	EPHB2 EPHA6 EPHA7	1.68e-06	15	32	3	GO:0005005
GeneOntologyMolecularFunction	ephrin receptor activity	EPHB2 EPHA6 EPHA7	3.56e-06	19	32	3	GO:0005003
GeneOntologyMolecularFunction	kinase activity	EPHB2 TNIK EPHA6 MAP4K4 AK8 MINK1 PTK6 EPHA7	2.06e-05	764	32	8	GO:0016301
GeneOntologyMolecularFunction	protein kinase activity	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	3.74e-05	600	32	7	GO:0004672
GeneOntologyMolecularFunction	protein tyrosine kinase activity	EPHB2 EPHA6 PTK6 EPHA7	8.19e-05	145	32	4	GO:0004713
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	EPHB2 TNIK EPHA6 MAP4K4 AK8 MINK1 PTK6 EPHA7	8.84e-05	938	32	8	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	1.07e-04	709	32	7	GO:0016773
GeneOntologyMolecularFunction	nuclear receptor activity	NR4A3 NR6A1 STAT3	1.20e-04	60	32	3	GO:0004879
GeneOntologyMolecularFunction	ligand-activated transcription factor activity	NR4A3 NR6A1 STAT3	1.26e-04	61	32	3	GO:0098531
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	EPHB2 EPHA6 EPHA7	1.53e-04	65	32	3	GO:0004714
GeneOntologyMolecularFunction	axon guidance receptor activity	EPHB2 EPHA7	1.92e-04	13	32	2	GO:0008046
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	EPHB2 EPHA6 EPHA7	3.38e-04	85	32	3	GO:0019199
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NR4A3 STAT3	4.64e-04	20	32	2	GO:0035259
GeneOntologyMolecularFunction	histone acetyltransferase binding	CITED2 NR4A3	9.83e-04	29	32	2	GO:0035035
GeneOntologyBiologicalProcess	neuron projection morphogenesis	EPHB2 TNIK OR8A1 NR4A3 NYAP2 EPHA6 MAP4K4 MINK1 EPHA7	2.43e-06	802	32	9	GO:0048812
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	EPHB2 TNIK OR8A1 NR4A3 NYAP2 EPHA6 MAP4K4 MINK1 EPHA7	2.89e-06	819	32	9	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	EPHB2 TNIK OR8A1 NR4A3 NYAP2 EPHA6 MAP4K4 MINK1 EPHA7	3.10e-06	826	32	9	GO:0048858
GeneOntologyBiologicalProcess	neuron development	EPHB2 TNIK OR8A1 NR4A3 PCARE NYAP2 EPHA6 MAP4K4 MINK1 PTK6 EPHA7	7.06e-06	1463	32	11	GO:0048666
GeneOntologyBiologicalProcess	cell morphogenesis	EPHB2 TNIK OR8A1 NR4A3 NYAP2 EPHA6 MAP4K4 NBEAL2 MINK1 EPHA7	8.13e-06	1194	32	10	GO:0000902
GeneOntologyBiologicalProcess	microvillus assembly	TNIK MAP4K4 MINK1	1.08e-05	28	32	3	GO:0030033
GeneOntologyBiologicalProcess	neuron projection development	EPHB2 TNIK OR8A1 NR4A3 NYAP2 EPHA6 MAP4K4 MINK1 PTK6 EPHA7	1.55e-05	1285	32	10	GO:0031175
GeneOntologyBiologicalProcess	microvillus organization	TNIK MAP4K4 MINK1	1.96e-05	34	32	3	GO:0032528
GeneOntologyBiologicalProcess	axon guidance	EPHB2 OR8A1 NR4A3 EPHA6 EPHA7	7.21e-05	285	32	5	GO:0007411
GeneOntologyBiologicalProcess	neuron projection guidance	EPHB2 OR8A1 NR4A3 EPHA6 EPHA7	7.33e-05	286	32	5	GO:0097485
GeneOntologyBiologicalProcess	ephrin receptor signaling pathway	EPHB2 EPHA6 EPHA7	7.97e-05	54	32	3	GO:0048013
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	EPHB2 TNIK OR8A1 NR4A3 EPHA6 MINK1 EPHA7	1.22e-04	748	32	7	GO:0048667
GeneOntologyBiologicalProcess	regulation of growth	CITED2 FOXS1 SH3PXD2B RPTOR STAT3 PTK6 EPHA7	1.55e-04	777	32	7	GO:0040008
GeneOntologyBiologicalProcess	cellular response to leptin stimulus	NR4A3 STAT3	3.92e-04	19	32	2	GO:0044320
GeneOntologyBiologicalProcess	regulation of multicellular organism growth	FOXS1 SH3PXD2B STAT3	4.00e-04	93	32	3	GO:0040014
GeneOntologyBiologicalProcess	protein autophosphorylation	TNIK MINK1 PTK6 EPHA7	4.10e-04	228	32	4	GO:0046777
GeneOntologyBiologicalProcess	regulation of developmental growth	CITED2 FOXS1 SH3PXD2B STAT3 EPHA7	4.42e-04	421	32	5	GO:0048638
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection assembly	EPHB2 TNIK DNHD1 MAP4K4 MINK1 CFAP65	5.06e-04	670	32	6	GO:0120031
GeneOntologyBiologicalProcess	cell projection assembly	EPHB2 TNIK DNHD1 MAP4K4 MINK1 CFAP65	5.69e-04	685	32	6	GO:0030031
GeneOntologyBiologicalProcess	response to leptin	NR4A3 STAT3	5.78e-04	23	32	2	GO:0044321
GeneOntologyBiologicalProcess	positive regulation of JNK cascade	TNIK MAP4K4 MINK1	6.03e-04	107	32	3	GO:0046330
GeneOntologyBiologicalProcess	retinal ganglion cell axon guidance	EPHB2 EPHA7	6.30e-04	24	32	2	GO:0031290
GeneOntologyCellularComponent	neuron to neuron synapse	EPHB2 TNIK IGSF9B STAT3 MINK1 EPHA7	1.03e-04	523	31	6	GO:0098984
GeneOntologyCellularComponent	dendrite	EPHB2 RIN3 IGSF9B EPHA6 RPTOR MINK1 EPHA7	2.12e-04	858	31	7	GO:0030425
GeneOntologyCellularComponent	dendritic tree	EPHB2 RIN3 IGSF9B EPHA6 RPTOR MINK1 EPHA7	2.15e-04	860	31	7	GO:0097447
GeneOntologyCellularComponent	postsynaptic density	TNIK IGSF9B STAT3 MINK1 EPHA7	4.89e-04	451	31	5	GO:0014069
GeneOntologyCellularComponent	asymmetric synapse	TNIK IGSF9B STAT3 MINK1 EPHA7	6.30e-04	477	31	5	GO:0032279
GeneOntologyCellularComponent	postsynaptic specialization	TNIK IGSF9B STAT3 MINK1 EPHA7	8.01e-04	503	31	5	GO:0099572
GeneOntologyCellularComponent	somatodendritic compartment	EPHB2 RIN3 IGSF9B EPHA6 RPTOR MINK1 EPHA7	1.80e-03	1228	31	7	GO:0036477
GeneOntologyCellularComponent	postsynapse	EPHB2 TNIK IGSF9B STAT3 MINK1 EPHA7	3.40e-03	1018	31	6	GO:0098794
GeneOntologyCellularComponent	sperm flagellum	DNHD1 AK8 CFAP65	3.85e-03	214	31	3	GO:0036126
GeneOntologyCellularComponent	hippocampal mossy fiber to CA3 synapse	EPHB2 EPHA7	4.43e-03	67	31	2	GO:0098686
Domain	RECEPTOR_TYR_KIN_V_2	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	PS00791
Domain	RECEPTOR_TYR_KIN_V_1	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	PS00790
Domain	EphA2_TM	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	PF14575
Domain	Tyr_kinase_ephrin_rcpt	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	IPR016257
Domain	Eph_TM	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	IPR027936
Domain	Ephrin_rcpt_lig-bd_dom	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	IPR001090
Domain	Tyr_kinase_rcpt_V_CS	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	IPR001426
Domain	EPH_LBD	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	PS51550
Domain	EPH_lbd	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	SM00615
Domain	CNH	TNIK MAP4K4 MINK1	1.35e-06	14	30	3	SM00036
Domain	Ephrin_lbd	EPHB2 EPHA6 EPHA7	1.35e-06	14	30	3	PF01404
Domain	CNH	TNIK MAP4K4 MINK1	1.68e-06	15	30	3	PS50219
Domain	CNH_dom	TNIK MAP4K4 MINK1	1.68e-06	15	30	3	IPR001180
Domain	CNH	TNIK MAP4K4 MINK1	1.68e-06	15	30	3	PF00780
Domain	Protein_kinase_ATP_BS	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	1.82e-06	379	30	7	IPR017441
Domain	PROTEIN_KINASE_ATP	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	6.45e-06	459	30	7	PS00107
Domain	Ephrin_rec_like	EPHB2 EPHA6 EPHA7	8.40e-06	25	30	3	SM01411
Domain	Tyr-kin_ephrin_A/B_rcpt-like	EPHB2 EPHA6 EPHA7	8.40e-06	25	30	3	IPR011641
Domain	Prot_kinase_dom	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	9.75e-06	489	30	7	IPR000719
Domain	PROTEIN_KINASE_DOM	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	1.03e-05	493	30	7	PS50011
Domain	TyrKc	EPHB2 EPHA6 PTK6 EPHA7	1.15e-05	88	30	4	SM00219
Domain	Tyr_kinase_cat_dom	EPHB2 EPHA6 PTK6 EPHA7	1.15e-05	88	30	4	IPR020635
Domain	PROTEIN_KINASE_TYR	EPHB2 EPHA6 PTK6 EPHA7	1.69e-05	97	30	4	PS00109
Domain	Tyr_kinase_AS	EPHB2 EPHA6 PTK6 EPHA7	1.69e-05	97	30	4	IPR008266
Domain	Kinase-like_dom	EPHB2 TNIK EPHA6 MAP4K4 MINK1 PTK6 EPHA7	1.90e-05	542	30	7	IPR011009
Domain	Pkinase_Tyr	EPHB2 EPHA6 PTK6 EPHA7	5.18e-05	129	30	4	PF07714
Domain	Ser-Thr/Tyr_kinase_cat_dom	EPHB2 EPHA6 PTK6 EPHA7	6.74e-05	138	30	4	IPR001245
Domain	fn3	EPHB2 IGSF9B EPHA6 EPHA7	1.25e-04	162	30	4	PF00041
Domain	Ephrin_rec_like	EPHB2 EPHA7	1.36e-04	11	30	2	PF07699
Domain	SAM_1	EPHB2 EPHA6 EPHA7	1.75e-04	68	30	3	PF00536
Domain	FN3	EPHB2 IGSF9B EPHA6 EPHA7	2.09e-04	185	30	4	SM00060
Domain	-	EPHB2 EPHA6 EPHA7	2.16e-04	73	30	3	2.60.120.260
Domain	FN3	EPHB2 IGSF9B EPHA6 EPHA7	2.76e-04	199	30	4	PS50853
Domain	FN3_dom	EPHB2 IGSF9B EPHA6 EPHA7	3.32e-04	209	30	4	IPR003961
Domain	SAM	EPHB2 EPHA6 EPHA7	3.74e-04	88	30	3	SM00454
Domain	Galactose-bd-like	EPHB2 EPHA6 EPHA7	4.54e-04	94	30	3	IPR008979
Domain	SAM_DOMAIN	EPHB2 EPHA6 EPHA7	4.69e-04	95	30	3	PS50105
Domain	SAM	EPHB2 EPHA6 EPHA7	4.98e-04	97	30	3	IPR001660
Domain	-	EPHB2 EPHA6 EPHA7	6.45e-04	106	30	3	1.10.150.50
Domain	SH2	RIN3 STAT3 PTK6	7.19e-04	110	30	3	SM00252
Domain	SH2	RIN3 STAT3 PTK6	7.38e-04	111	30	3	PS50001
Domain	SH2	RIN3 STAT3 PTK6	7.57e-04	112	30	3	IPR000980
Domain	-	RIN3 STAT3 PTK6	7.57e-04	112	30	3	3.30.505.10
Domain	SAM/pointed	EPHB2 EPHA6 EPHA7	8.60e-04	117	30	3	IPR013761
Domain	Growth_fac_rcpt_	EPHB2 EPHA6 EPHA7	1.97e-03	156	30	3	IPR009030
Domain	zf-C4	NR4A3 NR6A1	2.47e-03	46	30	2	PF00105
Domain	NUCLEAR_REC_DBD_1	NR4A3 NR6A1	2.47e-03	46	30	2	PS00031
Domain	Znf_hrmn_rcpt	NR4A3 NR6A1	2.47e-03	46	30	2	IPR001628
Domain	Nuclear_hrmn_rcpt	NR4A3 NR6A1	2.47e-03	46	30	2	IPR001723
Domain	ZnF_C4	NR4A3 NR6A1	2.47e-03	46	30	2	SM00399
Domain	NUCLEAR_REC_DBD_2	NR4A3 NR6A1	2.47e-03	46	30	2	PS51030
Domain	-	NR4A3 NR6A1	2.58e-03	47	30	2	1.10.565.10
Domain	HOLI	NR4A3 NR6A1	2.69e-03	48	30	2	SM00430
Domain	Nucl_hrmn_rcpt_lig-bd	NR4A3 NR6A1	2.69e-03	48	30	2	IPR000536
Domain	Hormone_recep	NR4A3 NR6A1	2.69e-03	48	30	2	PF00104
Domain	-	NR4A3 NR6A1	3.77e-03	57	30	2	3.30.50.10
Domain	Znf_NHR/GATA	NR4A3 NR6A1	3.90e-03	58	30	2	IPR013088
Domain	SH3_2	SH3PXD2B PTK6	8.38e-03	86	30	2	IPR011511
Domain	SH3_2	SH3PXD2B PTK6	8.38e-03	86	30	2	PF07653
Pathway	WP_HIPPOYAP_SIGNALING	TNIK MAP4K4 MINK1	4.31e-06	22	21	3	M39821
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB2 EPHA6 EPHA7	1.66e-05	34	21	3	MM15025
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	TNIK MAP4K4 MINK1	2.14e-05	37	21	3	MM14899
Pathway	REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS	EPHB2 EPHA6 EPHA7	5.67e-05	51	21	3	M27311
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB2 EPHA6 EPHA7	1.17e-04	65	21	3	MM14911
Pathway	REACTOME_CELLULAR_RESPONSES_TO_STIMULI	CITED2 TNIK MAP4K4 RPTOR STAT3 MINK1 PTK6	1.32e-04	828	21	7	M27827
Pathway	REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION	NR6A1 STAT3	1.63e-04	13	21	2	M27209
Pathway	REACTOME_CELLULAR_SENESCENCE	TNIK MAP4K4 STAT3 MINK1	1.84e-04	197	21	4	M27188
Pathway	REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE	EPHA6 EPHA7	3.19e-04	18	21	2	MM15023
Pathway	REACTOME_EPH_EPHRIN_SIGNALING	EPHB2 EPHA6 EPHA7	3.29e-04	92	21	3	M27201
Pathway	REACTOME_CELLULAR_SENESCENCE	TNIK MAP4K4 MINK1	6.98e-04	119	21	3	MM14901
Pathway	REACTOME_CELLULAR_RESPONSES_TO_STIMULI	CITED2 TNIK MAP4K4 RPTOR MINK1	7.31e-04	505	21	5	MM15548
Pathway	REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE	TNIK MAP4K4 MINK1	8.05e-04	125	21	3	M27186
Pathway	REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE	EPHA6 EPHA7	8.38e-04	29	21	2	M27309
Pathway	KEGG_AXON_GUIDANCE	EPHB2 EPHA6 EPHA7	8.83e-04	129	21	3	M5539
Pathway	WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY	MAP4K4 RPTOR MINK1	9.43e-04	132	21	3	M39338
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS	NR6A1 STAT3	9.58e-04	31	21	2	M27393
Pathway	WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS	RPTOR STAT3	1.15e-03	34	21	2	M48081
Pathway	PID_EPHA_FWDPATHWAY	EPHA6 EPHA7	1.15e-03	34	21	2	M177
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT	EPHB2 STAT3	1.59e-03	40	21	2	M39798
Pathway	WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA	RPTOR STAT3	1.59e-03	40	21	2	M48337
Pathway	PID_EPHB_FWD_PATHWAY	EPHB2 MAP4K4	1.59e-03	40	21	2	M62
Pathway	WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER	EPHB2 STAT3	1.84e-03	43	21	2	M39788
Pathway	PID_TNF_PATHWAY	TNIK MAP4K4	2.10e-03	46	21	2	M128
Pathway	WP_MICROTUBULE_CYTOSKELETON_REGULATION	EPHB2 STAT3	2.29e-03	48	21	2	M39566
Pathway	REACTOME_SIGNALING_BY_PTK6	STAT3 PTK6	2.29e-03	48	21	2	MM15479
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR4A3 NR6A1	2.29e-03	48	21	2	MM14987
Pathway	REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY	NR4A3 NR6A1	2.78e-03	53	21	2	M8276
Pathway	WP_INTERFERON_TYPE_I_SIGNALING	RPTOR STAT3	2.89e-03	54	21	2	M39435
Pathway	REACTOME_SIGNALING_BY_PTK6	STAT3 PTK6	2.89e-03	54	21	2	M29742
Pubmed	HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia.	EPHB2 EPHA6 EPHA7	8.45e-08	10	32	3	17304517
Pubmed	Competition is a driving force in topographic mapping.	EPHB2 EPHA6 EPHA7	1.16e-07	11	32	3	22065784
Pubmed	Rap2A links intestinal cell polarity to brush border formation.	TNIK MAP4K4 MINK1	3.19e-07	15	32	3	22797597
Pubmed	Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis.	EPHB2 EPHA6 EPHA7	3.93e-07	16	32	3	8755474
Pubmed	Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice.	EPHB2 EPHA6 EPHA7	4.77e-07	17	32	3	12217323
Pubmed	Expression of Ephs and ephrins in developing mouse inner ear.	EPHB2 EPHA6 EPHA7	6.79e-07	19	32	3	12684176
Pubmed	STAT3-EphA7 axis contributes to the progression of esophageal squamous cell carcinoma.	STAT3 EPHA7	8.20e-07	2	32	2	37738252
Pubmed	Disruption of the mouse protein tyrosine kinase 6 gene prevents STAT3 activation and confers resistance to azoxymethane.	STAT3 PTK6	8.20e-07	2	32	2	21741923
Pubmed	Knockdown of long noncoding RNA AC245100.4 inhibits the tumorigenesis of prostate cancer cells via the STAT3/NR4A3 axis.	NR4A3 STAT3	8.20e-07	2	32	2	34657447
Pubmed	Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee.	EPHB2 EPHA6 EPHA7	9.30e-07	21	32	3	9267020
Pubmed	Eph receptors and ephrins demarcate cerebellar lobules before and during their formation.	EPHB2 EPHA6 EPHA7	9.30e-07	21	32	3	10495276
Pubmed	Developmental expression of Eph and ephrin family genes in mammalian small intestine.	EPHB2 EPHA6 EPHA7	9.30e-07	21	32	3	20112066
Pubmed	Roles of Eph receptors and ephrins in segmental patterning.	EPHB2 EPHA6 EPHA7	9.30e-07	21	32	3	11128993
Pubmed	Eph receptors and ephrins: regulators of guidance and assembly.	EPHB2 EPHA6 EPHA7	9.30e-07	21	32	3	10730216
Pubmed	The protein tyrosine kinase family of the human genome.	EPHB2 EPHA6 PTK6 EPHA7	1.03e-06	83	32	4	11114734
Pubmed	Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling.	EPHB2 EPHA6 EPHA7	1.24e-06	23	32	3	19542359
Pubmed	Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions.	EPHB2 EPHA6 EPHA7	1.24e-06	23	32	3	25480914
Pubmed	Eph receptors and their ephrin ligands are expressed in developing mouse pancreas.	EPHB2 EPHA6 EPHA7	1.41e-06	24	32	3	16446123
Pubmed	Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells.	STAT3 PTK6	2.46e-06	3	32	2	20929863
Pubmed	STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation.	STAT3 PTK6	2.46e-06	3	32	2	19393627
Pubmed	Identification of STAT3 as a specific substrate of breast tumor kinase.	STAT3 PTK6	2.46e-06	3	32	2	16568091
Pubmed	Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.	STAT3 PTK6	2.46e-06	3	32	2	22547065
Pubmed	MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1.	TNIK MINK1	2.46e-06	3	32	2	18930710
Pubmed	Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation.	EPHB2 EPHA6 EPHA7	3.79e-06	33	32	3	26830346
Pubmed	cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases.	EPHB2 EPHA7	4.92e-06	4	32	2	7898931
Pubmed	Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature.	EPHB2 EPHA6 EPHA7	7.93e-06	42	32	3	11439183
Pubmed	Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk.	EPHB2 EPHA7	8.19e-06	5	32	2	10932185
Pubmed	Differential Roles of the mTOR-STAT3 Signaling in Dermal γδ T Cell Effector Function in Skin Inflammation.	RPTOR STAT3	8.19e-06	5	32	2	31167146
Pubmed	Rapamycin-Resistant mTOR Activity Is Required for Sensory Axon Regeneration Induced by a Conditioning Lesion.	RPTOR STAT3	8.19e-06	5	32	2	28101526
Pubmed	Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.	RPTOR STAT3	1.23e-05	6	32	2	24687132
Pubmed	Opposing gradients of ephrin-As and EphA7 in the superior colliculus are essential for topographic mapping in the mammalian visual system.	EPHA6 EPHA7	1.23e-05	6	32	2	15996548
Pubmed	Expression and requirement of T-box transcription factors Tbx2 and Tbx3 during secondary palate development in the mouse.	EPHB2 EPHA6 EPHA7	1.43e-05	51	32	3	19769959
Pubmed	PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands.	EPHB2 EPHA7	1.72e-05	7	32	2	9883737
Pubmed	Mistargeting hippocampal axons by expression of a truncated Eph receptor.	EPHA6 EPHA7	2.29e-05	8	32	2	12124402
Pubmed	Genetic analysis of ephrin-A2 and ephrin-A5 shows their requirement in multiple aspects of retinocollicular mapping.	EPHA6 EPHA7	2.29e-05	8	32	2	10774725
Pubmed	Degenerate PCR-based cloning method for Eph receptors and analysis of their expression in the developing murine central nervous system and vasculature.	EPHB2 EPHA7	2.94e-05	9	32	2	11403717
Pubmed	PDZ-domain-mediated interaction of the Eph-related receptor tyrosine kinase EphB3 and the ras-binding protein AF6 depends on the kinase activity of the receptor.	EPHB2 EPHA7	2.94e-05	9	32	2	9707552
Pubmed	Embryonic expression of EphA receptor genes in mice supports their candidacy for involvement in cleft lip and palate.	EPHA6 EPHA7	3.67e-05	10	32	2	25073978
Pubmed	Quantitative assessment of computational models for retinotopic map formation.	EPHA6 EPHA7	3.67e-05	10	32	2	25367067
Pubmed	EphrinA5 Signaling Is Required for the Distinctive Targeting of Raphe Serotonin Neurons in the Forebrain.	EPHA6 EPHA7	3.67e-05	10	32	2	28197551
Pubmed	Gata2 is required for the development of inner ear semicircular ducts and the surrounding perilymphatic space.	EPHB2 NR4A3	3.67e-05	10	32	2	20652952
Pubmed	EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.	EPHA6 EPHA7	3.67e-05	10	32	2	16547242
Pubmed	Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5.	EPHA6 EPHA7	4.49e-05	11	32	2	10559410
Pubmed	Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.	EPHB2 STAT3 PTK6	4.57e-05	75	32	3	15951569
Pubmed	The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis.	TNIK SH3PXD2B NYAP2 MAP4K4	4.71e-05	218	32	4	33378226
Pubmed	Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.	EPHB2 TNIK MAP4K4	5.14e-05	78	32	3	17192257
Pubmed	Ephrin/ephrin receptor expression during early stages of mouse inner ear development.	EPHB2 EPHA7	5.38e-05	12	32	2	21465626
Pubmed	The Hippo pathway kinases LATS1 and LATS2 attenuate cellular responses to heavy metals through phosphorylating MTF1.	MAP4K4 MINK1	5.38e-05	12	32	2	35027733
Pubmed	Epidermal hyperproliferation in mice lacking fatty acid transport protein 4 (FATP4) involves ectopic EGF receptor and STAT3 signaling.	EPHB2 STAT3	6.36e-05	13	32	2	20513444
Pubmed	Eph-ephrin A system regulates murine blastocyst attachment and spreading.	EPHA6 EPHA7	6.36e-05	13	32	2	17039519
Pubmed	EphA family gene expression in the developing mouse neocortex: regional patterns reveal intrinsic programs and extrinsic influence.	EPHA6 EPHA7	6.36e-05	13	32	2	12528186
Pubmed	Ephrin Ligands and Eph Receptors Show Regionally Restricted Expression in the Developing Palate and Tongue.	EPHA6 EPHA7	7.41e-05	14	32	2	26941654
Pubmed	A role for the EphA family in the topographic targeting of vomeronasal axons.	EPHA6 EPHA7	7.41e-05	14	32	2	11222144
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	EPHB2 IGSF9B EPHA6	8.13e-05	91	32	3	28558017
Pubmed	PHF6-mediated transcriptional control of NSC via Ephrin receptors is impaired in the intellectual disability syndrome BFLS.	EPHB2 EPHA7	9.76e-05	16	32	2	38429579
Pubmed	Cited2 Regulates Neocortical Layer II/III Generation and Somatosensory Callosal Projection Neuron Development and Connectivity.	CITED2 EPHA7	1.24e-04	18	32	2	27307230
Pubmed	Tracheal separation is driven by NKX2-1-mediated repression of Efnb2 and regulation of endodermal cell sorting.	EPHB2 EPHA7	1.39e-04	19	32	2	35294885
Pubmed	Multiple roles of EPH receptors and ephrins in neural development.	EPHB2 EPHA7	1.54e-04	20	32	2	11256076
Pubmed	The ephrins and Eph receptors in neural development.	EPHB2 EPHA7	1.54e-04	20	32	2	9530499
Pubmed	Eph receptors and ephrins: effectors of morphogenesis.	EPHB2 EPHA7	1.54e-04	20	32	2	10207129
Pubmed	Epidermal inactivation of the glucocorticoid receptor triggers skin barrier defects and cutaneous inflammation.	EPHB2 STAT3	1.54e-04	20	32	2	22951731
Pubmed	The Eph family receptors and ligands.	EPHB2 EPHA7	1.54e-04	20	32	2	9576626
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	EPHB2 IGSF9B MAP4K4 MINK1 PTK6 EPHA7	1.60e-04	910	32	6	36736316
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	TNIK MAP4K4 NBEAL2 MINK1 EPHA7	1.61e-04	569	32	5	30639242
Pubmed	Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis.	RPTOR STAT3	1.70e-04	21	32	2	23637172
Pubmed	PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord.	EPHB2 EPHA6 EPHA7	1.71e-04	117	32	3	17145500
Pubmed	Twist is required for patterning the cranial nerves and maintaining the viability of mesodermal cells.	EPHB2 CITED2	1.87e-04	22	32	2	15162501
Pubmed	Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS.	EPHB2 EPHA6	2.05e-04	23	32	2	24360543
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TNIK SH3PXD2B NYAP2 MAP4K4 RPTOR MINK1	2.17e-04	963	32	6	28671696
Pubmed	LZTR1 is a regulator of RAS ubiquitination and signaling.	TNIK MAP4K4 MINK1	2.18e-04	127	32	3	30442766
Pubmed	FBXL5 Inactivation in Mouse Brain Induces Aberrant Proliferation of Neural Stem Progenitor Cells.	RPTOR STAT3	2.43e-04	25	32	2	28069738
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	TINAGL1 DNHD1 C11orf24 IGSF9B EPHA6 NBEAL2	2.45e-04	985	32	6	12975309
Pubmed	Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions.	RPTOR STAT3	3.51e-04	30	32	2	22056141
Pubmed	The transcription factor gene Nfib is essential for both lung maturation and brain development.	EPHB2 NFIC	3.51e-04	30	32	2	15632069
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	MAP4K4 NFIC MINK1 PTK6	3.65e-04	372	32	4	22939624
Pubmed	Yap and Taz are required for Ret-dependent urinary tract morphogenesis.	EPHB2 EPHA7	3.75e-04	31	32	2	26243870
Pubmed	Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes.	RIN3 EPHA7	4.00e-04	32	32	2	21546767
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	PRICKLE3 MAP4K4 NFIC RPTOR MINK1	6.59e-04	774	32	5	15302935
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	EPHB2 CITED2 NR4A3 PRICKLE3 RPTOR STAT3	7.08e-04	1203	32	6	29180619
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	CITED2 ZNF438 NR6A1 PRICKLE3 STAT3	8.00e-04	808	32	5	20412781
Pubmed	mTORC1 accelerates retinal development via the immunoproteasome.	RPTOR STAT3	8.28e-04	46	32	2	29950673
Pubmed	Identification of NPM-ALK interacting proteins by tandem mass spectrometry.	EPHB2 STAT3	8.64e-04	47	32	2	14968112
Interaction	SLC9A8 interactions	MAP4K4 MINK1 EPHA7	6.70e-06	25	30	3	int:SLC9A8
Interaction	EPHB2 interactions	EPHB2 TNIK EPHA6 MAP4K4 EPHA7	1.55e-05	216	30	5	int:EPHB2
Interaction	NCKAP1 interactions	EPHB2 TNIK RIN3 NYAP2 EPHA7	1.62e-05	218	30	5	int:NCKAP1
Interaction	NCK1 interactions	EPHB2 TNIK SH3PXD2B MAP4K4 MINK1	2.78e-05	244	30	5	int:NCK1
Interaction	MAP4K4 interactions	EPHB2 TNIK MAP4K4 MINK1 EPHA7	3.37e-05	254	30	5	int:MAP4K4
Interaction	EPHA7 interactions	EPHB2 TNIK MAP4K4 MINK1 EPHA7	5.54e-05	282	30	5	int:EPHA7
Interaction	EPHA5 interactions	TNIK MAP4K4 STAT3 MINK1	5.93e-05	144	30	4	int:EPHA5
Interaction	KCNE3 interactions	TNIK PRICKLE3 MAP4K4 MINK1 EPHA7	6.97e-05	296	30	5	int:KCNE3
Interaction	EPHA2 interactions	EPHB2 TNIK EPHA6 MAP4K4 NFIC MINK1 EPHA7	7.10e-05	719	30	7	int:EPHA2
Interaction	FOS interactions	EPHB2 NR4A3 NR6A1 NFIC STAT3	8.93e-05	312	30	5	int:FOS
Interaction	SH3KBP1 interactions	EPHB2 TNIK SH3PXD2B RIN3 STAT3	9.34e-05	315	30	5	int:SH3KBP1
Interaction	CYFIP2 interactions	EPHB2 TNIK RIN3 NYAP2 EPHA7	1.05e-04	323	30	5	int:CYFIP2
Interaction	AFDN interactions	EPHB2 PRICKLE3 MAP4K4 MINK1 EPHA7	1.21e-04	333	30	5	int:AFDN
Interaction	EFNA5 interactions	EPHB2 EPHA6 EPHA7	1.40e-04	68	30	3	int:EFNA5
Interaction	NLK interactions	RPTOR FAM222B STAT3	1.52e-04	70	30	3	int:NLK
Interaction	CTTNBP2NL interactions	TNIK MAP4K4 MINK1	1.66e-04	72	30	3	int:CTTNBP2NL
Interaction	MINK1 interactions	TNIK MAP4K4 MINK1 EPHA7	1.84e-04	193	30	4	int:MINK1
Interaction	CSF1R interactions	EPHB2 STAT3 EPHA7	1.87e-04	75	30	3	int:CSF1R
Interaction	TSC1 interactions	TNIK RIN3 RPTOR FAM222B MINK1	1.88e-04	366	30	5	int:TSC1
Interaction	NTRK3 interactions	TNIK MAP4K4 RPTOR MINK1 EPHA7	2.08e-04	374	30	5	int:NTRK3
Interaction	TNIK interactions	EPHB2 TNIK MAP4K4 MINK1 EPHA7	2.27e-04	381	30	5	int:TNIK
Interaction	FGFR1 interactions	TNIK SH3PXD2B MAP4K4 STAT3 MINK1 PTK6	2.90e-04	632	30	6	int:FGFR1
Interaction	ABI1 interactions	EPHB2 TNIK RIN3 MINK1	3.19e-04	223	30	4	int:ABI1
Interaction	GALNT13 interactions	TNIK MINK1	3.23e-04	18	30	2	int:GALNT13
Interaction	RAP2A interactions	TNIK MAP4K4 MINK1	3.31e-04	91	30	3	int:RAP2A
Interaction	FGFR1OP2 interactions	TNIK MAP4K4 MINK1	3.64e-04	94	30	3	int:FGFR1OP2
Interaction	STRIP1 interactions	TNIK MAP4K4 MINK1	3.99e-04	97	30	3	int:STRIP1
Interaction	EFNA1 interactions	EPHB2 EPHA6 EPHA7	4.76e-04	103	30	3	int:EFNA1
Interaction	FGFR4 interactions	TNIK SH3PXD2B MAP4K4 STAT3 EPHA7	5.29e-04	458	30	5	int:FGFR4
Interaction	SEC23A interactions	EPHB2 TNIK EPHA6 EPHA7	5.30e-04	255	30	4	int:SEC23A
Interaction	HNRNPCL3 interactions	MAP4K4 MINK1	5.32e-04	23	30	2	int:HNRNPCL3
Interaction	ABL2 interactions	EPHB2 STAT3 EPHA7	5.32e-04	107	30	3	int:ABL2
Interaction	LCK interactions	RIN3 MAP4K4 STAT3 MINK1 PTK6	5.55e-04	463	30	5	int:LCK
Interaction	NR6A1 interactions	NR4A3 NR6A1	5.79e-04	24	30	2	int:NR6A1
Interaction	LYN interactions	TNIK IGSF9B MAP4K4 STAT3 MINK1 EPHA7	5.80e-04	720	30	6	int:LYN
Interaction	NCK2 interactions	TNIK SH3PXD2B MAP4K4 MINK1	5.86e-04	262	30	4	int:NCK2
Interaction	EPHA3 interactions	EPHB2 STAT3 EPHA7	5.92e-04	111	30	3	int:EPHA3
Interaction	WASF1 interactions	EPHB2 TNIK NYAP2	6.74e-04	116	30	3	int:WASF1
Interaction	NANOS2 interactions	MAP4K4 MINK1	6.81e-04	26	30	2	int:NANOS2
Interaction	FANCD2OS interactions	MAP4K4 MINK1	6.81e-04	26	30	2	int:FANCD2OS
Interaction	CAMKV interactions	TINAGL1 TNIK PRICKLE3	7.08e-04	118	30	3	int:CAMKV
Interaction	TUBA1B interactions	EPHB2 RIN3 RPTOR MINK1 PTK6	7.72e-04	498	30	5	int:TUBA1B
Interaction	OCLN interactions	EPHB2 TNIK MAP4K4 MINK1 EPHA7	7.86e-04	500	30	5	int:OCLN
GeneFamily	Fibronectin type III domain containing\|Sterile alpha motif domain containing\|EPH receptors	EPHB2 EPHA6 EPHA7	3.56e-07	14	19	3	1095
GeneFamily	Fibronectin type III domain containing	EPHB2 IGSF9B EPHA6 EPHA7	2.06e-05	160	19	4	555
GeneFamily	Sterile alpha motif domain containing	EPHB2 EPHA6 EPHA7	1.02e-04	88	19	3	760
GeneFamily	Nuclear hormone receptors	NR4A3 NR6A1	1.19e-03	49	19	2	71
GeneFamily	SH2 domain containing	STAT3 PTK6	4.97e-03	101	19	2	741
GeneFamily	WD repeat domain containing	RPTOR NBEAL2	3.04e-02	262	19	2	362
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000	CITED2 FOXS1 RIN3 NFIC STAT3	1.15e-05	214	30	5	gudmap_developingGonad_e16.5_testes_1000_k5
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#4_top-relative-expression-ranked_1000	CITED2 FOXS1 RIN3 NFIC STAT3	5.19e-05	293	30	5	gudmap_developingGonad_e18.5_testes_1000_k4
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#4_top-relative-expression-ranked_1000	CITED2 FOXS1 RIN3 NFIC STAT3	7.76e-05	319	30	5	gudmap_developingGonad_P2_testes_1000_k4
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000	TINAGL1 CITED2 FOXS1 RIN3 NFIC FAM222B STAT3	1.16e-04	819	30	7	gudmap_developingGonad_e16.5_testes_1000
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	EPHB2 NR4A3 SH3PXD2B STAT3	9.89e-06	189	32	4	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	EPHB2 NR4A3 SH3PXD2B STAT3	1.10e-05	194	32	4	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	TCGA-Ovary-Primary_Tumor\|TCGA-Ovary / Sample_Type by Project: Shred V9	EPHB2 CITED2 FAM222B	6.00e-05	106	32	3	14f548be39cec604fbdae0382cbf434fa4049840
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma\|TCGA-Ovary / Sample_Type by Project: Shred V9	EPHB2 CITED2 FAM222B	6.00e-05	106	32	3	939b80950d39cdc7149a05fdfb64c8810064cdb1
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma\|TCGA-Ovary / Sample_Type by Project: Shred V9	EPHB2 CITED2 FAM222B	6.00e-05	106	32	3	e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Adenocarcinoma-5\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	SCART1 NYAP2 NBEAL2	6.17e-05	107	32	3	5277cd6b854307444646c10277abb2c818c48b56
ToppCell	Posterior_cortex-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TINAGL1 FOXS1 PTK6	8.67e-05	120	32	3	a320799ab5f2ce872e038b15841a23174c5436e8
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AGXT2 IGSF9B PTK6	1.99e-04	159	32	3	709b57f992a29878cc899d760d144d36cb5cb280
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	NR4A3 NR6A1 AK8	2.14e-04	163	32	3	f4fcac0af9967ec34a43c9674aa17b0aa5344cf6
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF438 NBEAL2 MINK1	2.14e-04	163	32	3	4be3158f2a0ab460cfea8080a7370922910b5da9
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_GGT8P\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	AGXT2 PRICKLE3 FREM1	2.26e-04	166	32	3	9fa8510adfa3050ee182b4b71e5655abb9bb8a76
ToppCell	droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TINAGL1 NR4A3 RPTOR	2.30e-04	167	32	3	774f3264318b002d0df5d06d41d645366038d0bf
ToppCell	facs-Tongue-nan-3m-Epithelial-basal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF9B FREM1 EPHA7	2.34e-04	168	32	3	ca0c4a819f9047fc40d224f7656fec60f6fa05d8
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|343B / Donor, Lineage, Cell class and subclass (all cells)	NR4A3 NR6A1 MINK1	2.38e-04	169	32	3	2098f15a388d019ed7f1d4c209affd5ca2886dcc
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-ILC3\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CITED2 NR4A3 SCART1	2.47e-04	171	32	3	6ab7f103cbdbd49ef687cbb8a42ddc5517af0f7f
ToppCell	COVID-19_Convalescent\|World / Disease Group and Platelet Clusters	CITED2 ZNF438 STAT3	2.64e-04	175	32	3	e9b1faa4c85537f30306619a2f3ada6c8ef0ac6c
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CITED2 NR4A3 RIN3	2.82e-04	179	32	3	3d3716078afdb9a89ddfadb3197cd1b52fa770be
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CITED2 TNIK STAT3	2.87e-04	180	32	3	f3d35b2ea78afef37a84232adf5e6e26712b618d
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NR6A1 PRICKLE3 NBEAL2	2.91e-04	181	32	3	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 EPHA7	2.91e-04	181	32	3	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 EPHA7	2.91e-04	181	32	3	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	EPHB2 EPHA6 FREM1	2.96e-04	182	32	3	72e65a23cd36085bc880087d3cae92395de918a1
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	NYAP2 NR6A1 NBEAL2	3.01e-04	183	32	3	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NYAP2 NR6A1 NBEAL2	3.01e-04	183	32	3	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAGL1 CITED2 FOXS1	3.06e-04	184	32	3	31dbe6119a3bcd266ae5e9b340c853d9ff680dce
ToppCell	facs-Heart-RV-3m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TINAGL1 CITED2 FOXS1	3.06e-04	184	32	3	9c20b50f8d6ac689d41d5440c835f9db8d04758b
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 FREM1 CFAP65	3.06e-04	184	32	3	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 FREM1 CFAP65	3.06e-04	184	32	3	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AK8 FREM1 CFAP65	3.06e-04	184	32	3	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NYAP2 EPHA6 FREM1	3.16e-04	186	32	3	310d16f4e5cffee3ea6d7635508c513a3b92131e
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	CITED2 TNIK IGSF9B	3.16e-04	186	32	3	c793a3d5709ad504c12fc3b2337746d90236d3ca
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NR4A3 RIN3 NBEAL2	3.16e-04	186	32	3	305f1726b8b5add32f1c29c74991ff34f42e0da7
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK NR6A1 EPHA7	3.16e-04	186	32	3	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 FOXS1 NR4A3	3.21e-04	187	32	3	6820bfbe552ea5e62cfe699687b051a17d9fda61
ToppCell	COVID-19-kidney-Stressed_PCT\|kidney / Disease (COVID-19 only), tissue and cell type	TNIK AGXT2 EPHA7	3.21e-04	187	32	3	acd305475f3609800af0d7bc68d83ef41228080b
ToppCell	10x5'v1-week_17-19-Myeloid_macrophage-stroma-osteoclast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	SH3PXD2B NYAP2 MAP4K4	3.26e-04	188	32	3	762b52f21d2bc5409f86746a904c4358490be9c0
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	SH3PXD2B EPHA6 FREM1	3.26e-04	188	32	3	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	COPD-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	TINAGL1 FOXS1 IGSF9B	3.26e-04	188	32	3	9ffef4b01d0ddd6913c9ed6be79aeaaabd5e41ed
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 EPHA7	3.31e-04	189	32	3	13fd07cc408a9486f61a7b2c3a132c52d14b438d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 EPHA7	3.31e-04	189	32	3	204ab61ae606b2d9be0cb6bf6a83a011740693a8
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK EPHA6 EPHA7	3.31e-04	189	32	3	28b502611829e4a24caff2562545c7db97686099
ToppCell	COVID-19-kidney-PCT-S2\|kidney / Disease (COVID-19 only), tissue and cell type	TNIK AGXT2 EPHA7	3.31e-04	189	32	3	0be5c669b6b308bd98ddb70c84877c62a6244bbd
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 EPHA7	3.36e-04	190	32	3	989d4eefd22d66ecb857836f8fdbcf41e3047f84
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK NBEAL2 FREM1	3.41e-04	191	32	3	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 NR6A1	3.41e-04	191	32	3	3c464645d0e7e423f791bd63bf5bcf11f6b590d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK AGXT2 NR6A1	3.41e-04	191	32	3	1c1d13144259b998d4a0e85142f7afef2ef1e63f
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CITED2 NR4A3 RIN3	3.41e-04	191	32	3	79e7089022063c5f2b2f1b27658c62b741f3a037
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NYAP2 EPHA6 FREM1	3.41e-04	191	32	3	fa50a3c7ff86e1ee07100da1ace0b0fa1b0ab26b
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NYAP2 EPHA6 FREM1	3.41e-04	191	32	3	7b386512284dfaa0e95358b28ee82632ee965e64
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 FOXS1 NR4A3	3.46e-04	192	32	3	71863f18a82394ed9f8e5ec8a4017215382a8284
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TINAGL1 NYAP2 PTK6	3.46e-04	192	32	3	0b954a4e5857dac45d97c491af9b27cb2d1bd339
ToppCell	MatrixFB-Fibroblast-D_(Pericyte)\|MatrixFB / shred on cell class and cell subclass (v4)	TINAGL1 FOXS1 MINK1	3.46e-04	192	32	3	630444302511f511ec6976bc045a3b4b9d8d4547
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	NR4A3 FREM1 STAT3	3.46e-04	192	32	3	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	LA-14._Fibroblast_III\|LA / Chamber and Cluster_Paper	NR4A3 SH3PXD2B STAT3	3.52e-04	193	32	3	7426c291bac59e539c427bcaae18abc7d397d44e
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 FOXS1 MAP4K4	3.52e-04	193	32	3	a9349ed5f3c34dcf817b3e84737e5946922ddff3
ToppCell	PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	TINAGL1 IGSF9B EPHA6	3.57e-04	194	32	3	efd5efed060edb7f24d59600981bb60ec28ac2ef
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK NBEAL2 FREM1	3.57e-04	194	32	3	69bff17df4a760ccf081cf52ff04af02c14f448d
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNIK NBEAL2 FREM1	3.57e-04	194	32	3	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	10x5'v1-week_12-13-Hematopoietic-MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CITED2 TNIK FREM1	3.57e-04	194	32	3	245a3eb6db9c862b73ad34a8cd2898a3688c16f6
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 FOXS1 NR4A3	3.57e-04	194	32	3	3b9ada901dfe7a5cc4861a883d3268c53b11e5b6
ToppCell	medial-2-Hematologic-Myeloid_Dendritic_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EPHB2 NR4A3 RIN3	3.62e-04	195	32	3	54a404ee1b97d0659fcffafb20d11f878ed453d4
ToppCell	medial-Hematologic-Myeloid_Dendritic_Type_2-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EPHB2 NR4A3 RIN3	3.62e-04	195	32	3	35a5302b8b3e76bc92dc38979400c979f0e86550
ToppCell	10x5'v1-week_12-13-Hematopoietic-MK-early_MK\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	CITED2 TNIK FREM1	3.62e-04	195	32	3	fa5fc6f605deb5cae96eec14ba4000b19f877ba6
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CITED2 TNIK STAT3	3.62e-04	195	32	3	e4caa01d2040a6f4dd90e68c2e1e99c5405e2eba
ToppCell	medial-Hematologic-Myeloid_Dendritic_Type_2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EPHB2 NR4A3 RIN3	3.62e-04	195	32	3	c0d1ecb378bb482a8e08d7065fcca07a65687dac
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	TINAGL1 SH3PXD2B RIN3	3.62e-04	195	32	3	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	10x5'v1-week_17-19-Myeloid_neutrophil-granulo-eo/baso/mast\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CITED2 TNIK FREM1	3.62e-04	195	32	3	f1f48e2e57b2282572959b152aad4bee05143f03
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR4A3 SH3PXD2B RIN3	3.62e-04	195	32	3	62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105
ToppCell	10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	TNIK NR4A3 RIN3	3.68e-04	196	32	3	5bb8653af62334ded8aad48b24b64d7b54bc3cd5
ToppCell	facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-skeletal_muscle_satellite_cell\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CITED2 MAP4K4 STAT3	3.68e-04	196	32	3	97ac47daf5bb07fa5dda3976e1ae402750f959b5
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TINAGL1 FOXS1 NR4A3	3.68e-04	196	32	3	624f700daea48d9bad4cc554f4776bd809ae1e54
ToppCell	Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC\|Transverse / shred on region, Cell_type, and subtype	DNHD1 NR6A1 PRICKLE3	3.73e-04	197	32	3	15b87fd3906d7388c271d30d0c64b1bcc490801c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	NR4A3 SH3PXD2B RIN3	3.73e-04	197	32	3	1eb9ff8467118b943b5d443cb996168e1e1206b5
ToppCell	Transverse-Dendritic_cell-Lymphoid_DC\|Transverse / Region, Cell class and subclass	DNHD1 NR6A1 PRICKLE3	3.73e-04	197	32	3	a58af0ea82f76f2a7abac1f62629ff20d552fc63
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	CITED2 TNIK STAT3	3.79e-04	198	32	3	c4d8d133e571ad3a7c5de93aa7befb67cb7a003d
ToppCell	10x3'2.3-week_14-16-Hematopoietic-MK-early_MK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CITED2 TNIK FREM1	3.79e-04	198	32	3	fcf53d6ac2e442400fa0c07c6de72e00a9143ba2
ToppCell	Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TINAGL1 FOXS1 IGSF9B	3.79e-04	198	32	3	7dd874b09c81cc512ccc1e9b65f290a5f94d736e
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK OR8A1 RIN3	3.79e-04	198	32	3	cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4\|lymph-node_spleen / Manually curated celltypes from each tissue	CITED2 TNIK STAT3	3.79e-04	198	32	3	2cbafcb03df3c9aca68371df500d18ab8dcc416c
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Mast_cell\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK OR8A1 RIN3	3.79e-04	198	32	3	d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCell	5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB2 NBEAL2 FREM1	3.85e-04	199	32	3	f544229f471b4717166dd4b588399afe45cc31b5
ToppCell	mLN-T_cell\|mLN / Region, Cell class and subclass	CITED2 TNIK STAT3	3.85e-04	199	32	3	caa37ec509b54e842564d754f100ab1b2a77a7c1
ToppCell	mLN-(1)_T_cell\|mLN / shred on region, Cell_type, and subtype	CITED2 TNIK STAT3	3.85e-04	199	32	3	4bf2641409c543c2167bff71efa95b00dd7bfe19
ToppCell	5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB2 NBEAL2 FREM1	3.90e-04	200	32	3	fc77a0c53201c60933d188ea8d4d86bac6325422
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK OR8A1 RIN3	3.90e-04	200	32	3	c3511607692e05f44538a376253673dd18f77908
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	NYAP2 EPHA6 FREM1	3.90e-04	200	32	3	d0167f96314be78b6d867bbcc6e4396071d931b8
ToppCell	5'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EPHB2 NBEAL2 FREM1	3.90e-04	200	32	3	742441800a2d167c19cee4816ff77424ae6675c6
ToppCell	Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TNIK OR8A1 RIN3	3.90e-04	200	32	3	1c58860932ed47263a5a537a64f0343201463c21
Drug	troglitazone; Up 200; 10uM; PC3; HG-U133A	TINAGL1 CITED2 NR4A3 NBEAL2 FAM222B STAT3	2.25e-07	195	31	6	431_UP
Drug	Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A	CITED2 TNIK PRICKLE3 FAM222B MINK1	6.21e-06	195	31	5	4235_DN
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	CITED2 RIN3 NBEAL2 MINK1 PTK6	6.69e-06	198	31	5	6328_UP
Drug	Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; PC3; HT_HG-U133A	TINAGL1 CITED2 TNIK RIN3 MINK1	6.69e-06	198	31	5	5815_UP
Drug	vandetanib	TNIK EPHA6 PTK6 EPHA7	9.67e-06	99	31	4	CID003081361
Drug	columbamine	EPHB2 STAT3	5.00e-05	8	31	2	ctd:C055786
Drug	BIRB796	TNIK EPHA6 EPHA7	9.87e-05	66	31	3	CID000156422
Drug	ponatinib	EPHB2 PTK6 EPHA7	1.08e-04	68	31	3	ctd:C545373
Drug	Helveticoside [630-64-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	TINAGL1 PRICKLE3 MINK1 PTK6	1.12e-04	185	31	4	4327_DN
Drug	Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A	TINAGL1 MINK1 PTK6 EPHA7	1.32e-04	193	31	4	4338_DN
Drug	Haloperidol [52-86-8]; Down 200; 10.6uM; PC3; HT_HG-U133A	EPHB2 RIN3 FAM222B PTK6	1.34e-04	194	31	4	4678_DN
Drug	Cefotiam hydrochloride; Down 200; 7.2uM; PC3; HT_HG-U133A	EPHB2 TINAGL1 CITED2 PRICKLE3	1.37e-04	195	31	4	6762_DN
Drug	Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A	EPHB2 NBEAL2 MINK1 PTK6	1.37e-04	195	31	4	3504_DN
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; MCF7; HT_HG-U133A	EPHB2 PRICKLE3 NBEAL2 MINK1	1.37e-04	195	31	4	3451_DN
Drug	Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A	NR4A3 RIN3 NR6A1 PRICKLE3	1.37e-04	195	31	4	1162_UP
Drug	Amoxapine [14028-44-5]; Down 200; 12.8uM; PC3; HT_HG-U133A	EPHB2 TNIK RIN3 MINK1	1.37e-04	195	31	4	6650_DN
Drug	Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A	EPHB2 TINAGL1 TNIK RIN3	1.37e-04	195	31	4	6648_DN
Drug	(1)-Nipecotic acid [498-95-3]; Down 200; 31uM; HL60; HT_HG-U133A	NR4A3 RIN3 NBEAL2 MINK1	1.40e-04	196	31	4	3121_DN
Drug	Hydrocortisone base [50-23-7]; Down 200; 11uM; MCF7; HT_HG-U133A	EPHB2 NR6A1 PRICKLE3 MINK1	1.40e-04	196	31	4	3284_DN
Drug	novobiocin sodium, USP; Down 200; 100uM; ssMCF7; HG-U133A	TNIK NR4A3 C11orf24 MAP4K4	1.40e-04	196	31	4	499_DN
Drug	Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A	EPHB2 RIN3 NFIC PTK6	1.40e-04	196	31	4	6602_DN
Drug	Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A	EPHB2 TNIK RIN3 FAM222B	1.40e-04	196	31	4	5091_DN
Drug	Glutethimide, para-amino [125-84-8]; Down 200; 17.2uM; MCF7; HT_HG-U133A	EPHB2 PRICKLE3 FAM222B MINK1	1.42e-04	197	31	4	7463_DN
Drug	Ungerine nitrate; Up 200; 10.2uM; PC3; HT_HG-U133A	EPHB2 TINAGL1 NR6A1 PRICKLE3	1.42e-04	197	31	4	5816_UP
Drug	Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A	TNIK PRICKLE3 NFIC FAM222B	1.42e-04	197	31	4	5746_DN
Drug	Miconazole [22916-47-8]; Down 200; 9.6uM; HL60; HG-U133A	C11orf24 MAP4K4 NFIC FAM222B	1.45e-04	198	31	4	1977_DN
Drug	Trichlorfon [52-68-6]; Down 200; 15.6uM; PC3; HT_HG-U133A	EPHB2 PRICKLE3 MINK1 PTK6	1.45e-04	198	31	4	1797_DN
Drug	Iobenguane sulfate; Up 200; 10.8uM; PC3; HT_HG-U133A	EPHB2 TINAGL1 PRICKLE3 EPHA7	1.45e-04	198	31	4	7299_UP
Drug	Nifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A	CITED2 PRICKLE3 NBEAL2 MINK1	1.45e-04	198	31	4	7303_DN
Drug	Methacycline hydrochloride [3963-95-9]; Down 200; 8.4uM; PC3; HT_HG-U133A	EPHB2 TNIK RIN3 PTK6	1.45e-04	198	31	4	4062_DN
Drug	(-)-MK 801 hydrogen maleate [77086-19-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	EPHB2 NFIC NBEAL2 PTK6	1.48e-04	199	31	4	5003_DN
Drug	Orphenadrine hydrochloride [341-69-5]; Down 200; 13uM; PC3; HT_HG-U133A	EPHB2 FAM222B MINK1 PTK6	1.48e-04	199	31	4	4537_DN
Drug	estradiol, USP; Down 200; 0.01uM; PC3; HT_HG-U133A	EPHB2 TINAGL1 PRICKLE3 PTK6	1.48e-04	199	31	4	1241_DN
Drug	Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A	TINAGL1 RIN3 MINK1 PTK6	1.48e-04	199	31	4	3696_DN
Drug	CAY10397; Up 200; 10uM; MCF7; HT_HG-U133A	NR6A1 FAM222B MINK1 PTK6	1.51e-04	200	31	4	7082_UP
Drug	EKB-569	TNIK EPHA6 STAT3	2.24e-04	87	31	3	CID006445562
Disease	epilepsy (implicated_via_orthology)	TNIK PRICKLE3 MAP4K4 MINK1	2.86e-05	163	32	4	DOID:1826 (implicated_via_orthology)
Disease	Eye Abnormalities	SH3PXD2B FREM1	1.53e-04	17	32	2	C0015393
Disease	Congenital hernia of foramen of Morgagni	FREM1 STAT3	1.93e-04	19	32	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	FREM1 STAT3	1.93e-04	19	32	2	C0265700
Disease	serum homoarginine measurement	TINAGL1 AGXT2	2.14e-04	20	32	2	EFO_0005421
Disease	Congenital diaphragmatic hernia	FREM1 STAT3	2.36e-04	21	32	2	C0235833
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Positive	TNIK NR4A3 STAT3	3.86e-04	131	32	3	C4704862
Disease	Polyarthritis, Juvenile, Rheumatoid Factor Negative	TNIK NR4A3 STAT3	3.86e-04	131	32	3	C4552091
Disease	Juvenile arthritis	TNIK NR4A3 STAT3	3.86e-04	131	32	3	C3495559
Disease	Juvenile psoriatic arthritis	TNIK NR4A3 STAT3	3.86e-04	131	32	3	C3714758
Disease	Juvenile-Onset Still Disease	TNIK NR4A3 STAT3	4.22e-04	135	32	3	C0087031
Disease	serum metabolite measurement	TINAGL1 TNIK AGXT2 EPHA6 STAT3 EPHA7	4.72e-04	945	32	6	EFO_0005653
Disease	cortical surface area measurement	TINAGL1 ZNF438 TNIK RIN3 NYAP2 MAP4K4 EPHA7	4.97e-04	1345	32	7	EFO_0010736
Disease	immunoglobulin isotype switching measurement	RIN3 STAT3	1.05e-03	44	32	2	EFO_0010128
Disease	cortical thickness	ZNF438 TNIK SH3PXD2B RIN3 NYAP2 EPHA7	1.11e-03	1113	32	6	EFO_0004840
Disease	severe acute respiratory syndrome, COVID-19	EPHB2 RIN3 FAM222B EPHA7	1.34e-03	447	32	4	EFO_0000694, MONDO_0100096
Disease	body fat percentage	RIN3 IGSF9B NYAP2 RPTOR	1.84e-03	488	32	4	EFO_0007800
Disease	chronic kidney disease	TINAGL1 RIN3 EPHA7	2.09e-03	235	32	3	EFO_0003884

Protein segments in the cluster

Peptide	Gene	Start	Entry
SLHTKPRMPPCDFMP	AGXT2	41	Q9BYV1
MAECKAQMHLLPSPP	DNHD1	4376	Q96M86
MAEGAPPLCDMHPMR	MAP4K4	226	O95819
MAMRLHFQPPHPNCL	CFAP65	711	Q6ZU64
PPPMDCPSALHQLML	EPHB2	846	P29323
MDATIAPHRIPPEMP	AK8	1	Q96MA6
PTPMPSCVVNPMEHT	FAM222B	316	Q8WU58
VAYMPPMQDIGPHCR	FREM1	731	Q5H8C1
FMTMPAPQDRLPHPC	NYAP2	96	Q9P242
PAPMDCPAGLHQLML	EPHA7	856	Q15375
MPCPLECPPSVHKLM	PTK6	406	Q13882
PPHLCRPMPAQDTAM	PRICKLE3	571	O43900
SMCPATTDGRPRPPM	FOXS1	176	O43638
PMHPCRPPTQRRMAA	OR8A1	6	Q8NGG7
CEMEGNLEHLPPPPM	PCARE	821	A6NGG8
DHPNQPPMMTCERLP	RIN3	331	Q8TB24
PAPMGCPASLHQLML	EPHA6	896	Q9UF33
MAEGAPPLCDMHPMR	MINK1	226	Q8N4C8
PPSPPICMMNALVRA	NR4A3	391	Q92570
THQPNRFPDLMMCLP	NR6A1	431	Q15406
DEAGPAPPCMMHSRA	TINAGL1	301	Q9GZM7
NMAVEGDHSMCPPPP	NBEAL2	431	Q6ZNJ1
KMPSHCLSAQMLAPP	NFIC	431	P08651
HPLAQMPLPPSMKNC	RPTOR	226	Q8N122
MPASVAHVPAAMLPP	CITED2	201	Q99967
HMPSDTAASPVPPMR	C11orf24	236	Q96F05
MAEGAPPLCDMHPMR	TNIK	226	Q9UKE5
ETPAMMFPHQLPPCD	IGSF9B	1051	Q9UPX0
LPMMPAKHIPPARDS	SH3PXD2B	561	A1X283
QPCMPMHPDRPLVIK	STAT3	326	P40763
AQLHSVAMPFPPMAP	SCART1	736	Q4G0T1
AQTQMCPQMSPSPPH	ZNF438	151	Q7Z4V0